
ALCON INC
ALCNYSETrading Snapshot
- Day Range
- $72.14 β $72.77
- 52-Week Range
- $47.80 β $72.88
- Volume
- $2.43B
- Avg Volume
- $2.26B
- Shares Outstanding
- 499.7M
- Next Earnings
- Sep 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $10.40B
- Last Q Revenue
- $2.65B
- P/E Ratio
- 43.3
- P/S Ratio
- 3.3x
- EPS (TTM)
- $1.66
- Dividend Yield
- 0.47%
Why Investors Own ALC
- βHigh-growth profile β revenue up -7.6% YoY with expanding US Equity exposure.
- βHealthy economics β 58% gross margin and 26% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ALCON INC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The companyβs cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ALCON INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ALC price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ALCON INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.